J&J Medical Connect
SYMTUZA®

(darunavir/ cobicistat/ emtricitabine/ tenofovir alafenamide)

J&J Medical Connect

Connect with us

  • Products

This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

SYMTUZA® (darunavir/ cobicistat/ emtricitabine/ tenofovir alafenamide)
Medical Information

SYMTUZA - Missed Dose

Last Updated: 07/21/2026

SUMMARY

  • If a dose of SYMTUZA is missed within 12 hours of the time it is usually taken, patients should be instructed to take the prescribed dose of SYMTUZA with food as soon as possible. If a missed dose is noticed later than 12 hours after the time it is usually taken, it should not be taken and the patient should resume the usual dosing schedule.1

Literature Search

A literature search of MEDLINE®, Embase®, BIOSIS Previews®, and Derwent Drug File (and/or other resources, including internal/external databases) pertaining to this topic was conducted on 28 August 2025. No relevant literature pertaining to this topic was identified.

References

Show
1 Data on File. Darunavir/Cobicistat/Emtricitabine/Tenofovir alafenamide. Company Core Data Sheet. Janssen Research & Development, LLC. EDMS-ERI-119231875; 2021.  

Would you like to clear and leave your conversation? Message history will be lost.